The following information has been received by ANCO.
****CMS NEWS****
The Centers for Medicare & Medicaid Services (CMS) has made available the Medicare Part B Drug and Biological Average Sales Price (ASP) Payment Amounts for January 1, 2009 to March 31, 2009 on the CMS website at http://www.cms.hhs.gov/McrPartBDrugAvgSalesPrice/01a1_2009aspfiles.asp#TopOfPage. The files are located in the "Downloads" section of this web page.
Tuesday, December 16, 2008
ACCC News
The following information has been received by ANCO.
****ACCC NEWS****
The Association of Community Cancer Center's (ACCC) This Week At ACCC was published today and is available online at http://www.accc-cancer.org/mediaroom/newsletters/media_ACCCNEWSLETTER_12-15-2008.html. It features:
ACCC's Hospital Summit Highlights Trends in Cancer Care
CMS Offers PQRI Conference Call Tomorrow
Save the Date: March 18-21, 2009, ACCC's 35th Annual National Meeting
Oncology Review Journal Available Online to ACCC Members
Q&A on ACCC's Listserv: E & M Services on the Same Day As Chemotherapy
ACCC's CE Blackboard: Update on Multiple Myeloma
Take Our Survey: Oncology Issues and ACCC's Website
State Medical Oncology Societies Host Membership Meetings
****ACCC NEWS****
The Association of Community Cancer Center's (ACCC) This Week At ACCC was published today and is available online at http://www.accc-cancer.org/mediaroom/newsletters/media_ACCCNEWSLETTER_12-15-2008.html. It features:
ACCC's Hospital Summit Highlights Trends in Cancer Care
CMS Offers PQRI Conference Call Tomorrow
Save the Date: March 18-21, 2009, ACCC's 35th Annual National Meeting
Oncology Review Journal Available Online to ACCC Members
Q&A on ACCC's Listserv: E & M Services on the Same Day As Chemotherapy
ACCC's CE Blackboard: Update on Multiple Myeloma
Take Our Survey: Oncology Issues and ACCC's Website
State Medical Oncology Societies Host Membership Meetings
Sunday, December 14, 2008
Oncology ERx Demo
The following e-Prescribing demonstration is being made available for ANCO members by OnPoint.
Roberta Buell invites you to participate as an attendee in the following online training session:
Topic: Oncology ERx Demo
Host: Roberta Buell
Date: Monday, December 22, 2008
Time: 11:00AM Pacific Standard Time
Session number: 576 823 503
Session password: queenb
-------------------------------------------------------
To join the training session
-------------------------------------------------------
1. Go to https://shp.webex.com/shp/k2/j.php?ED=116139172&UID=1042670477
2. Enter your name and email address.
3. Enter the session password: queenb
4. Click "Join Now".
5. Follow the instructions that appear on your screen.
Note: You can view more information about the session at https://shp.webex.com/shp/k2/j.php?ED=116139172&UID=1042670477.
-------------------------------------------------------
To join the teleconference only
-------------------------------------------------------
Call-in toll-free number (US/Canada):
866-469-3239
Global call-in numbers: https://shp.webex.com/shp/globalcallin.php?serviceType=TC&ED=116139172&tollFree=1
Show toll-free dialing restrictions: http://www.webex.com/pdf/tollfree_restrictions.pdf
-------------------------------------------------------
For assistance
-------------------------------------------------------
You can contact Roberta Buell at:
bbuell@covad.net
1-800-795-2633
To add this meeting to your calendar program (for example Microsoft Outlook), click this link:
https://shp.webex.com/shp/k2/j.php?AT=down&ED=116139172&EF=MA&UUID=1042670477&SHA2=rkuXDWcz9nPwRwYzmMJVFWoGl/G70EceT2MHqRgMfkg=
EVERY provider in Oncology can benefit from e-prescribing and ALL can participate - it is an easy additional revenue stream for every practice large and small. According to the CMS call a few weeks ago – a “qualified” product (see below) must be CCHIT 2008 certified – at present there is still no Oncology specific EMR’s (if they have one) that has achieved this certification yet. OnPoint has researched all solutions thoroughly and we are endorsing and helping to build www.oncologyerx.com. There is a demo on the site. This product is no more than the Allscripts e-prescribing module carved out as a stand alone, web-based (ASP) application. It is tried and true (been used in practices for over 10 years) and has been rated the best e-prescribing module for ANY EMR (including Next-Gen and all the rest that are not really in the Oncology space). It is an excellent product and was hand-picked by a diverse panel of experts. The overall initiative is being sponsored by some major
companies including Cisco, Microsoft, etc. who all believe as we do – that e-prescribing is good medicine – check this page out - http://www.nationalerx.com/sponsors.htm to see the list if interested.
Behind the scenes:
Smart ID out of Grand Rapids, Mi (also a large Oncology practice) is a sponsor of this initiative. You may already recognize them – they have been in business for about 6 years and they are the current vehicle by which oral drug dispensing systems are installed into Oncology practices – they do all the credentialing, software installation, etc. so the progression to this was natural – they acquired the rights to this free product in Oncology and are hosting this as vehicle for our practices. OnPoint Oncology and Smart ID will build additional oncology specific functionality on top of an already excellent platform.
The problem:
Oncology is very late, when compared to other specialties, to adopt e-prescribing technology because the oncology space is very difficult for technology companies to tackle. Oncology EMR companies have not had the functionality to support e-prescribing and no physician has had much incentive to e-prescribe until now. Even still, only about 15% all oncology practices have EMR’s and at present everyone’s only true alternative will be to purchase one (average price is $10,000) or use this free one. The offices are scrambling – onPoint has done much research to determine that this is one of the few times EVER that free is really free - Thanks Bill Gates - Technical stuff below…
THE TECHNICAL STUFF:
Medicare has updated their document explaining the E-prescribing incentive program. It is titled “Medicare’s Practical Guide to the E-prescribing Incentive Program.” It can be found here:
http://www.cms.hhs.gov/partnerships/downloads/11399.pdf
Oncologyerx.com meets all the requirements of a qualified system found on page 7 of the guide.
The requirements of a qualified E-prescribing system are:
1. Generate a complete medication list that incorporates data from pharmacies and benefit managers (if available)
2. Select medications, transmit prescriptions electronically* using the applicable standards, and warn the prescriber of possible undesirable or unsafe situations
3. Provide information on lower-cost, therapeutically-appropriate alternatives (for 2009, tiered formulary information, if available, meets this requirement)
4. Provide information on formulary or tiered formulary medications, patient eligibility, and authorization requirements received electronically from the patient’s drug plan
Another requirement of a qualified system is to be able to send the prescription electronically. Oncologyerx.com supports this functionality as well.
Sign up at http://www.oncologyerx.com today to earn an additional 2% from Medicare!
Roberta Buell invites you to participate as an attendee in the following online training session:
Topic: Oncology ERx Demo
Host: Roberta Buell
Date: Monday, December 22, 2008
Time: 11:00AM Pacific Standard Time
Session number: 576 823 503
Session password: queenb
-------------------------------------------------------
To join the training session
-------------------------------------------------------
1. Go to https://shp.webex.com/shp/k2/j.php?ED=116139172&UID=1042670477
2. Enter your name and email address.
3. Enter the session password: queenb
4. Click "Join Now".
5. Follow the instructions that appear on your screen.
Note: You can view more information about the session at https://shp.webex.com/shp/k2/j.php?ED=116139172&UID=1042670477.
-------------------------------------------------------
To join the teleconference only
-------------------------------------------------------
Call-in toll-free number (US/Canada):
866-469-3239
Global call-in numbers: https://shp.webex.com/shp/globalcallin.php?serviceType=TC&ED=116139172&tollFree=1
Show toll-free dialing restrictions: http://www.webex.com/pdf/tollfree_restrictions.pdf
-------------------------------------------------------
For assistance
-------------------------------------------------------
You can contact Roberta Buell at:
bbuell@covad.net
1-800-795-2633
To add this meeting to your calendar program (for example Microsoft Outlook), click this link:
https://shp.webex.com/shp/k2/j.php?AT=down&ED=116139172&EF=MA&UUID=1042670477&SHA2=rkuXDWcz9nPwRwYzmMJVFWoGl/G70EceT2MHqRgMfkg=
EVERY provider in Oncology can benefit from e-prescribing and ALL can participate - it is an easy additional revenue stream for every practice large and small. According to the CMS call a few weeks ago – a “qualified” product (see below) must be CCHIT 2008 certified – at present there is still no Oncology specific EMR’s (if they have one) that has achieved this certification yet. OnPoint has researched all solutions thoroughly and we are endorsing and helping to build www.oncologyerx.com. There is a demo on the site. This product is no more than the Allscripts e-prescribing module carved out as a stand alone, web-based (ASP) application. It is tried and true (been used in practices for over 10 years) and has been rated the best e-prescribing module for ANY EMR (including Next-Gen and all the rest that are not really in the Oncology space). It is an excellent product and was hand-picked by a diverse panel of experts. The overall initiative is being sponsored by some major
companies including Cisco, Microsoft, etc. who all believe as we do – that e-prescribing is good medicine – check this page out - http://www.nationalerx.com/sponsors.htm to see the list if interested.
Behind the scenes:
Smart ID out of Grand Rapids, Mi (also a large Oncology practice) is a sponsor of this initiative. You may already recognize them – they have been in business for about 6 years and they are the current vehicle by which oral drug dispensing systems are installed into Oncology practices – they do all the credentialing, software installation, etc. so the progression to this was natural – they acquired the rights to this free product in Oncology and are hosting this as vehicle for our practices. OnPoint Oncology and Smart ID will build additional oncology specific functionality on top of an already excellent platform.
The problem:
Oncology is very late, when compared to other specialties, to adopt e-prescribing technology because the oncology space is very difficult for technology companies to tackle. Oncology EMR companies have not had the functionality to support e-prescribing and no physician has had much incentive to e-prescribe until now. Even still, only about 15% all oncology practices have EMR’s and at present everyone’s only true alternative will be to purchase one (average price is $10,000) or use this free one. The offices are scrambling – onPoint has done much research to determine that this is one of the few times EVER that free is really free - Thanks Bill Gates - Technical stuff below…
THE TECHNICAL STUFF:
Medicare has updated their document explaining the E-prescribing incentive program. It is titled “Medicare’s Practical Guide to the E-prescribing Incentive Program.” It can be found here:
http://www.cms.hhs.gov/partnerships/downloads/11399.pdf
Oncologyerx.com meets all the requirements of a qualified system found on page 7 of the guide.
The requirements of a qualified E-prescribing system are:
1. Generate a complete medication list that incorporates data from pharmacies and benefit managers (if available)
2. Select medications, transmit prescriptions electronically* using the applicable standards, and warn the prescriber of possible undesirable or unsafe situations
3. Provide information on lower-cost, therapeutically-appropriate alternatives (for 2009, tiered formulary information, if available, meets this requirement)
4. Provide information on formulary or tiered formulary medications, patient eligibility, and authorization requirements received electronically from the patient’s drug plan
Another requirement of a qualified system is to be able to send the prescription electronically. Oncologyerx.com supports this functionality as well.
Sign up at http://www.oncologyerx.com today to earn an additional 2% from Medicare!
CMS News
The following information has been received by ANCO.
****CMS NEWS****
Registration will close at 3:30 p.m. EST, December 15, 2008, or when available space has been filled. No exceptions will be made, so please be sure to register prior to this time.
2008 Physician Quality Reporting Initiative
National Provider Question & Answer Session
The Centers for Medicare & Medicaid Services’ (CMS) Provider Communications Group will host the ninth in a series of national provider conference calls that began in November of 2007 on the 2008 Physician Quality Reporting Initiative (PQRI). This toll-free call will take place from 3:30 p.m. – 5:00 p.m., EST, on Tuesday, December 16, 2008.
Following a short presentation on the final PQRI 2007 reporting experience and a discussion of results from 2007, the lines will be opened to allow participants to ask questions of CMS PQRI subject matter experts.
Educational products are available on the PQRI dedicated web page located at http://www.cms.hhs.gov/PQRI on the CMS website, in the Educational Resources section.
Feel free to download the resources prior to the call so that you may ask questions of the presenters, Dr. Michael Rapp and Dr. Daniel Green.
Conference call details:
Date: December 16, 2008
Conference Title: 2008 Physician Quality Reporting Initiative National Provider Call
Time: 3:30-5:00 p.m. EST
In order to receive the call-in information, you must register for the call. It is important to note that if you are planning to sit in with a group, only one person needs to register to receive the call-in data. This registration is solely to reserve a phone line, NOT to allow participation. If you cannot attend the call, replay information is available below.
Registration will close at 3:30 p.m. EST on December 15, 2008, or when available space has been filled. No exceptions will be made, so please be sure to register prior to this time.
To register for the call participants need to go to http://www2.eventsvc.com/palmettogba/121608
Fill in all required data.
Verify your time zone is displayed correctly the drop down box.
Click "Register".
You will be taken to the “Thank you for registering” page and will receive a confirmation email shortly thereafter. Note: Please print and save this page, in the event that your server blocks the confirmation emails. If you do not receive the confirmation email, please check your spam/junk mail filter as it may have been directed there.
For those of you who will be unable to attend, a replay option will be available shortly following the end of the call. This replay will be accessible from 4:00 p.m. EST 12/16/2008 until 11:59 p.m. EST 12/23/2008. The call in data for the replay is (800) 642-1687 and the passcode is 76618434.
If you require services for the hearing impaired please send an email to Medicare.TTT@PalmettoGBA.com.
****CMS NEWS****
Registration will close at 3:30 p.m. EST, December 15, 2008, or when available space has been filled. No exceptions will be made, so please be sure to register prior to this time.
2008 Physician Quality Reporting Initiative
National Provider Question & Answer Session
The Centers for Medicare & Medicaid Services’ (CMS) Provider Communications Group will host the ninth in a series of national provider conference calls that began in November of 2007 on the 2008 Physician Quality Reporting Initiative (PQRI). This toll-free call will take place from 3:30 p.m. – 5:00 p.m., EST, on Tuesday, December 16, 2008.
Following a short presentation on the final PQRI 2007 reporting experience and a discussion of results from 2007, the lines will be opened to allow participants to ask questions of CMS PQRI subject matter experts.
Educational products are available on the PQRI dedicated web page located at http://www.cms.hhs.gov/PQRI on the CMS website, in the Educational Resources section.
Feel free to download the resources prior to the call so that you may ask questions of the presenters, Dr. Michael Rapp and Dr. Daniel Green.
Conference call details:
Date: December 16, 2008
Conference Title: 2008 Physician Quality Reporting Initiative National Provider Call
Time: 3:30-5:00 p.m. EST
In order to receive the call-in information, you must register for the call. It is important to note that if you are planning to sit in with a group, only one person needs to register to receive the call-in data. This registration is solely to reserve a phone line, NOT to allow participation. If you cannot attend the call, replay information is available below.
Registration will close at 3:30 p.m. EST on December 15, 2008, or when available space has been filled. No exceptions will be made, so please be sure to register prior to this time.
To register for the call participants need to go to http://www2.eventsvc.com/palmettogba/121608
Fill in all required data.
Verify your time zone is displayed correctly the drop down box.
Click "Register".
You will be taken to the “Thank you for registering” page and will receive a confirmation email shortly thereafter. Note: Please print and save this page, in the event that your server blocks the confirmation emails. If you do not receive the confirmation email, please check your spam/junk mail filter as it may have been directed there.
For those of you who will be unable to attend, a replay option will be available shortly following the end of the call. This replay will be accessible from 4:00 p.m. EST 12/16/2008 until 11:59 p.m. EST 12/23/2008. The call in data for the replay is (800) 642-1687 and the passcode is 76618434.
If you require services for the hearing impaired please send an email to Medicare.TTT@PalmettoGBA.com.
Friday, December 12, 2008
Estimate the Impact of 2009 Medicare Fees
The following information has been received by ANCO.
As you know, the Centers for Medicare & Medicaid Services (CMS) has released the 2009 Physician Fee Schedule (PFS). This new fee schedule implements the 1.1% increase in physician services reimbursement that Congress mandated in the Improvement for Patients and Providers Act of 2008 Medicare bill, also known as MIPPA. On the surface, this was a short-term positive because it averted a 10.6% cut in services reimbursement, and replaced it with a slated increase of 1.1%. However, the devil is in the details at CMS. That is why we are providing a tool that will help you estimate the impact of the Medicare changes for 2009.
Go to the Community Oncology Alliance (COA) website at http://www.communityoncology.org and log into the Administrators’ Network temporary area. You can download the tool, which was developed and tested by actual community oncology practices as part of the COA Administrators’ Network in development. The tool will show you the impact on E&M and drug administration revenue, as well as the impact of bonus payments if you participate in the PQRI and/or e-prescribing programs.
In order to actually increase services payments by 1.1%, the Medicare PFS conversion factor decreases from $38.09 in 2008 to $36.07 in 2009, while the physician work value units increase by approximately 12%. The net is that E&M revenues will increase; however, oncology-specific drug administration codes will go down.
The PQRI bonus has been increased to 2% of services in 2009 and the new e-prescribing bonus is an additional 2% beginning in 2009.
The fact that drug administration fees will decrease in 2009 is simply ludicrous. This is the problem with blindly supporting increases to the Medicare PFS that can adversely impact community oncology.
As a result, COA has launched the most comprehensive study ever undertaken to identify and quantify the clinical and operational components of delivering cancer care. A committee drawn from the ranks of medical oncologists, mid-level providers, nurses, pharmacists, and administrators is advising one of the top healthcare policy and research firms in the country, which has been commissioned by COA. Community oncology practices from across the country will be asked to participate in this landmark study for community oncology. The data gathered will be instrumental in supporting a massive outreach program to the new Administration and Congress being developed by COA. More information on this study will be provided shortly.
As you know, the Centers for Medicare & Medicaid Services (CMS) has released the 2009 Physician Fee Schedule (PFS). This new fee schedule implements the 1.1% increase in physician services reimbursement that Congress mandated in the Improvement for Patients and Providers Act of 2008 Medicare bill, also known as MIPPA. On the surface, this was a short-term positive because it averted a 10.6% cut in services reimbursement, and replaced it with a slated increase of 1.1%. However, the devil is in the details at CMS. That is why we are providing a tool that will help you estimate the impact of the Medicare changes for 2009.
Go to the Community Oncology Alliance (COA) website at http://www.communityoncology.org and log into the Administrators’ Network temporary area. You can download the tool, which was developed and tested by actual community oncology practices as part of the COA Administrators’ Network in development. The tool will show you the impact on E&M and drug administration revenue, as well as the impact of bonus payments if you participate in the PQRI and/or e-prescribing programs.
In order to actually increase services payments by 1.1%, the Medicare PFS conversion factor decreases from $38.09 in 2008 to $36.07 in 2009, while the physician work value units increase by approximately 12%. The net is that E&M revenues will increase; however, oncology-specific drug administration codes will go down.
The PQRI bonus has been increased to 2% of services in 2009 and the new e-prescribing bonus is an additional 2% beginning in 2009.
The fact that drug administration fees will decrease in 2009 is simply ludicrous. This is the problem with blindly supporting increases to the Medicare PFS that can adversely impact community oncology.
As a result, COA has launched the most comprehensive study ever undertaken to identify and quantify the clinical and operational components of delivering cancer care. A committee drawn from the ranks of medical oncologists, mid-level providers, nurses, pharmacists, and administrators is advising one of the top healthcare policy and research firms in the country, which has been commissioned by COA. Community oncology practices from across the country will be asked to participate in this landmark study for community oncology. The data gathered will be instrumental in supporting a massive outreach program to the new Administration and Congress being developed by COA. More information on this study will be provided shortly.
ANCO's San Antonio Breast Cancer Symposium Highlights 2008
The Association of Northern California Oncologists (ANCO) & Indiana University present
San Antonio Breast Cancer Symposium Highlights 2008
Wednesday, January 14th, 2009; 5:30PM-9:15PM
Hotel Nikko, 222 Mason Street, San Francisco
(415) 394-1111
The Association of Northern California Oncologists was organized in 1990 to be an advocate for, educate, and inform the practicing oncologist and hematologist and represents 363 oncologists and hematologists throughout Northern California and other states.
San Antonio Breast Cancer Symposium Highlights 2008 will summarize the major research and treatment advancements presented at December 2008’s San Antonio Breast Cancer Symposium. The faculty will focus on surgical, radiation, and medical oncology treatment modalities and place these developments in context as to their immediate clinical utility.
At the conclusion of this educational activity, participants should be able to:
• Review, summarize, and interpret important clinical results presented at the San Antonio Breast Cancer Symposium for surgical, radiation, and medical oncologists; oncology nurses; and, other health care professionals.
• Comprehend and implement changes in surgical, radiological, and medical treatment for breast cancer.
San Antonio Breast Cancer Symposium Highlights 2008 has been designed to meet the educational needs of oncologists, oncology nurses, oncology pharmacists, and other health care professionals involved in the care of people with breast cancer.
Accreditation Statement and Designation of Credit. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Indiana University School of Medicine and the Association of Northern California Oncologists (ANCO). The Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Indiana University School of Medicine designates this educational activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The California Board of Registered Nurses accepts courses approved for AMA PRA Category 1 Credits™ as meeting the continuing education requirements for renewal.
Disclosure Statement. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and Planning Committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Program Planning Committee. The Physician Course Director for San Antonio Breast Cancer Symposium Highlights 2008 is Helen K. Chew, M.D., Univ. of California, Davis. Dr. Chew was assisted by the ANCO Board of Directors (Richard A. Bohannon, M.D., Norman Cohen, M.D., Jeffrey Cronk, M.D., Bradley Ekstrand, M.D., Ellie Guardino, M.D., Ph.D., John A. Keech, Jr., D.O., L. Wayne Keiser, M.D., Primo Lara, Jr., M.D., Daniel P. Mirda, M.D., Bimal J. Patel, M.D., Robert L. Robles, M.D., and Antoine Sayegh, M.D.,) and Group and Institutional Member contacts (George Fisher, M.D., David Gandara, M.D., Joseph Mason, M.D., Hope Rugo, M.D., and Margaret Tempero, M.D.) in the selection of the faculty for San Antonio Breast Cancer Symposium Highlights 2008.
Content Consultant. The Indiana University School of Medicine content consultant is Bryan Schneider, M.D.
Agenda & Faculty
5:30PM Registration, Exhibits, & Dinner (available through 7:00PM)
6:00PM Welcome, Introductions, & Talks (Richard A. Bohannon, M.D., ANCO President, & Helen K. Chew, M.D., Program Moderator, Univ. of California, Davis)
• Surgical Oncology (Michael Alvarado, M.D., Univ. of California, San Francisco)
• Radiation Oncology (Allen Chen, M.D., Univ. of California, Davis)
• Medical Oncology (Ellie Guardino, M.D., Ph.D., Stanford Univ.)
9:15PM Adjourn
Acknowledgment of Commercial Support. Support for this educational activity is anticipated in part from Abraxis Oncology, Agendia, AstraZeneca, Celgene, Cephalon Oncology, Eisai, Genentech BioOncology, GlaxoSmithKline Oncology, Ortho Biotech, Pfizer Oncology, Roche Oncology, Sanofi Aventis Oncology, and possibly others (as of the date of this mailing). The final list of supporters will be available at the meeting.
Download the meeting announcement/registration form at www.anco-online.org/sabcs.html.
San Antonio Breast Cancer Symposium Highlights 2008
Wednesday, January 14th, 2009; 5:30PM-9:15PM
Hotel Nikko, 222 Mason Street, San Francisco
(415) 394-1111
The Association of Northern California Oncologists was organized in 1990 to be an advocate for, educate, and inform the practicing oncologist and hematologist and represents 363 oncologists and hematologists throughout Northern California and other states.
San Antonio Breast Cancer Symposium Highlights 2008 will summarize the major research and treatment advancements presented at December 2008’s San Antonio Breast Cancer Symposium. The faculty will focus on surgical, radiation, and medical oncology treatment modalities and place these developments in context as to their immediate clinical utility.
At the conclusion of this educational activity, participants should be able to:
• Review, summarize, and interpret important clinical results presented at the San Antonio Breast Cancer Symposium for surgical, radiation, and medical oncologists; oncology nurses; and, other health care professionals.
• Comprehend and implement changes in surgical, radiological, and medical treatment for breast cancer.
San Antonio Breast Cancer Symposium Highlights 2008 has been designed to meet the educational needs of oncologists, oncology nurses, oncology pharmacists, and other health care professionals involved in the care of people with breast cancer.
Accreditation Statement and Designation of Credit. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Indiana University School of Medicine and the Association of Northern California Oncologists (ANCO). The Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Indiana University School of Medicine designates this educational activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The California Board of Registered Nurses accepts courses approved for AMA PRA Category 1 Credits™ as meeting the continuing education requirements for renewal.
Disclosure Statement. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and Planning Committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Program Planning Committee. The Physician Course Director for San Antonio Breast Cancer Symposium Highlights 2008 is Helen K. Chew, M.D., Univ. of California, Davis. Dr. Chew was assisted by the ANCO Board of Directors (Richard A. Bohannon, M.D., Norman Cohen, M.D., Jeffrey Cronk, M.D., Bradley Ekstrand, M.D., Ellie Guardino, M.D., Ph.D., John A. Keech, Jr., D.O., L. Wayne Keiser, M.D., Primo Lara, Jr., M.D., Daniel P. Mirda, M.D., Bimal J. Patel, M.D., Robert L. Robles, M.D., and Antoine Sayegh, M.D.,) and Group and Institutional Member contacts (George Fisher, M.D., David Gandara, M.D., Joseph Mason, M.D., Hope Rugo, M.D., and Margaret Tempero, M.D.) in the selection of the faculty for San Antonio Breast Cancer Symposium Highlights 2008.
Content Consultant. The Indiana University School of Medicine content consultant is Bryan Schneider, M.D.
Agenda & Faculty
5:30PM Registration, Exhibits, & Dinner (available through 7:00PM)
6:00PM Welcome, Introductions, & Talks (Richard A. Bohannon, M.D., ANCO President, & Helen K. Chew, M.D., Program Moderator, Univ. of California, Davis)
• Surgical Oncology (Michael Alvarado, M.D., Univ. of California, San Francisco)
• Radiation Oncology (Allen Chen, M.D., Univ. of California, Davis)
• Medical Oncology (Ellie Guardino, M.D., Ph.D., Stanford Univ.)
9:15PM Adjourn
Acknowledgment of Commercial Support. Support for this educational activity is anticipated in part from Abraxis Oncology, Agendia, AstraZeneca, Celgene, Cephalon Oncology, Eisai, Genentech BioOncology, GlaxoSmithKline Oncology, Ortho Biotech, Pfizer Oncology, Roche Oncology, Sanofi Aventis Oncology, and possibly others (as of the date of this mailing). The final list of supporters will be available at the meeting.
Download the meeting announcement/registration form at www.anco-online.org/sabcs.html.
Thursday, December 11, 2008
ASCO News
The following information has been received by ANCO.
****ASCO NEWS****
The American Society of Clinical Oncology's (ASCO) Cancer Policy Today was published today and is available online at http://view.exacttarget.com/?j=fe5a157870660075751d&m=ff311d707460&ls=fdec12777c65017975127971&l=fe601575776601757d14&s=fe1f15797d620479731d75&jb=ffcf14&ju=fe3416717360057e771c70. ANCO is a state/regional affiliate of ASCO. This edition features:
Update on ASCO's Electronic Prescribing Web site
ASCO Launches Health Information Technology Social Networking Site
FDA Issues Q&A on Medication Guides for ESAs
Diversity in Oncology Initiative Accepting Applications Starting December 15
ASCO/AMA Survey Update
****ASCO NEWS****
The American Society of Clinical Oncology's (ASCO) Cancer Policy Today was published today and is available online at http://view.exacttarget.com/?j=fe5a157870660075751d&m=ff311d707460&ls=fdec12777c65017975127971&l=fe601575776601757d14&s=fe1f15797d620479731d75&jb=ffcf14&ju=fe3416717360057e771c70. ANCO is a state/regional affiliate of ASCO. This edition features:
Update on ASCO's Electronic Prescribing Web site
ASCO Launches Health Information Technology Social Networking Site
FDA Issues Q&A on Medication Guides for ESAs
Diversity in Oncology Initiative Accepting Applications Starting December 15
ASCO/AMA Survey Update
Subscribe to:
Posts (Atom)